Drug intelligence / Profile preview

EpiCream

Development stage
Unknown
Lead developer
Primus Pharmaceuticals
Administration
Topical
01

Overview

EpiCream is a prescription-only topical skin barrier repair cream developed by Primus Pharmaceuticals. It is FDA-cleared as a medical device for the management and relief of burning and itching associated with various dermatoses, including atopic dermatitis, irritant contact dermatitis, and radiation dermatitis. The product is formulated with a physiological ratio of essential lipids—ceramides, cholesterol, and free fatty acids—that mimic the natural composition of the stratum corneum. By replenishing these lipids, EpiCream restores the skin's barrier integrity, reduces transepidermal water loss (TEWL), and protects the skin from environmental triggers, providing a non-steroidal option for managing inflammatory skin conditions.

Brand names
EpiCream
Other names
EpiCream Skin Barrier Repair Cream
02

Targets

PPARA (Peroxisome proliferator-activated receptor alpha)

Beyond the preview

Go deeper on EpiCream.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EpiCream.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call